These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 497524)

  • 1. Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol.
    Borys HK; Ingall GB; Karler R
    Br J Pharmacol; 1979 Sep; 67(1):93-101. PubMed ID: 497524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol.
    Bornheim LM; Correia MA
    Mol Pharmacol; 1989 Sep; 36(3):377-83. PubMed ID: 2779523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat.
    List A; Nazar B; Nyquist S; Harclerode J
    Drug Metab Dispos; 1977; 5(3):268-72. PubMed ID: 17525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potentiation of barbiturate-induced narcosis by procarbazine.
    Lee IP; Lucier GW
    J Pharmacol Exp Ther; 1976 Mar; 196(3):586-93. PubMed ID: 1263114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol.
    Bornheim LM; Correia MA
    Mol Pharmacol; 1990 Sep; 38(3):319-26. PubMed ID: 2402224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatic drug-metabolizing enzymes by arachidonic acid.
    Pessayre D; Mazel P; Descatoire V; Rogier E; Feldmann G; Benhamou JP
    Xenobiotica; 1979 May; 9(5):301-10. PubMed ID: 115160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver.
    Narimatsu S; Watanabe K; Yamamoto I; Yoshimura H
    Drug Metab Dispos; 1988; 16(6):880-9. PubMed ID: 2907469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cannabidiol on cytochrome P-450 isozymes.
    Bornheim LM; Correia MA
    Biochem Pharmacol; 1989 Sep; 38(17):2789-94. PubMed ID: 2550010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats.
    Yamada Y; Nakahara M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1989 Mar; 39(3):356-60. PubMed ID: 2502989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.
    Massi P; Vaccani A; Ceruti S; Colombo A; Abbracchio MP; Parolaro D
    J Pharmacol Exp Ther; 2004 Mar; 308(3):838-45. PubMed ID: 14617682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
    Bornheim LM; Kim KY; Li J; Perotti BY; Benet LZ
    Drug Metab Dispos; 1995 Aug; 23(8):825-31. PubMed ID: 7493549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant activity of four oxygenated cannabidiol derivatives.
    Carlini EA; Mechoulam R; Lander N
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):1-15. PubMed ID: 1188178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression of the hepatic cytochrome P-450 monooxygenase system by treatment of mice with the antineoplastic agent 5-azacytidine.
    Gooderham NJ; Mannering GJ
    Cancer Res; 1985 Apr; 45(4):1569-72. PubMed ID: 2579731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of cytochrome P-450 by the drug methoxsalen.
    Fouin-Fortunet H; Tinel M; Descatoire V; Letteron P; Larrey D; Geneve J; Pessayre D
    J Pharmacol Exp Ther; 1986 Jan; 236(1):237-47. PubMed ID: 3941395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.
    Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J
    Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of reactive oxygen species during mouse hepatic microsomal metabolism of cannabidiol and cannabidiol hydroxy-quinone.
    Usami N; Yamamoto I; Watanabe K
    Life Sci; 2008 Nov; 83(21-22):717-24. PubMed ID: 18929579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of caffeine on barbiturate sleeping time and brain level.
    Aeschbacher HU; Atkinson J; Domahidy B
    J Pharmacol Exp Ther; 1975 Mar; 192(3):635-41. PubMed ID: 1120961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hepatic microsomal cytochrome P450 by cannabidiol in adult male rats.
    Narimatsu S; Watanabe K; Matsunaga T; Yamamoto I; Imaoka S; Funae Y; Yoshimura H
    Chem Pharm Bull (Tokyo); 1990 May; 38(5):1365-8. PubMed ID: 2393963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of certain vitamin deficiencies on hepatic drug metabolism.
    Zannoni VG; Sato PH
    Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.